Table I.
Parameter | CASSS 0 | CASSS 1 | CASSS 2 | CASSS 3 | P-value |
---|---|---|---|---|---|
N (%) | 112 (27%) | 121 (30%) | 115 (28%) | 62 (15%) | – |
Age [years]* | 65.2 ±10.2 | 64.1 ±11.5 | 65.5 ±10.7 | 68.7 ±9.5 | 0.06 |
Sex (F/M) | 61 (15%)/51 (12%) | 36 (9%)/85 (21%) | 32 (8%)/83 (20%) | 15 (4%)/47 (12%) | < 0.001 |
25(OH)D [ng/ml]** | 16.8 (4.8–42.6) | 15.1 (4.0–48.4) | 13.6 (4.4–37.6) | 15.2 (5.0–42.9) | 0.07 |
Patients in groups according to the level of 25(OH)D: | |||||
0 – < 10 | 18 (4%) | 27 (7%) | 27 (7%) | 14 (3%) | 0.47 |
≥ 10 – < 20 | 56 (14%) | 68 (17%) | 66 (16%) | 32 (8%) | |
≥ 20 – < 30 | 29 (7%) | 20 (5%) | 18 (4%) | 13 (3%) | |
≥ 30 | 9 (2%) | 6 (1%) | 4 (1%) | 3 (1%) | |
Smoking (No/Yes/Ex-smokers) | 79 (19%)/15 (4%)/18 (4%) | 63 (15%)/44 (11%)/14 (3%) | 54 (13%)/33 (8%)/28 (7%) | 32 (8%)/16 (4%)/14 (3%) | < 0.001 |
Hyperlipidaemia (No/Yes) | 46 (12%)/63 (16%) | 61 (15%)/55 (14%) | 49 (12%)/64 (16%) | 34 (9%)/25 (6%) | 0.13 |
CAD status (stable CAD/ACS) | 96 (23%)/16 (4%) | 65 (16%)/56 (14%) | 74 (18%)/41 (10%) | 38 (9%)/24 (6%) | < 0.001 |
Data presented as mean ± SD;
data presented as median and range; other data presented as number of subjects (% of whole group).